Ambey Laboratories IPO GMP Today ( Grey Market Premium )

Ambey Laboratories IPO GMP Today

The Ambey Laboratories IPO commenced on July 4, 2024, and concluded on July 8, 2024. The allotment of shares took place on July 9, 2024, and the initiation of refunds began on July 10, 2024. The shares were credited to the demat accounts of investors on July 10, 2024. Finally, the listing of Ambey Laboratories on the stock exchange occurred on July 11, 2024.

The Ambey Laboratories IPO was priced at ₹65 to ₹68 per share, with a lot size of 2000 shares. The total size of Ambey Laboratories IPO is ₹44.68 crores out of which ₹42.55 crores is fresh issue and ₹2.12 crores is offer for sale (OFS). The IPO was listed on the NSE SME.

In terms of quota reservations, the QIB (Qualified Institutional Buyers) quota was reserved for 50% of the shares, the NII (Non-Institutional Investors) quota was reserved for 15% of the shares, and the retail quota was reserved for 35% of the shares.

Ambey Laboratories IPO Basic Details

Company NameAmbey Laboratories Limited
Aasaan Loans IPO GMP Today₹27
Aasaan Loans IPO Listing Gain39.71%
Aasaan Loans IPO Open DateJuly 4, 2024
Aasaan Loans IPO Close DateJuly 8, 2024
Aasaan Loans IPO Allotment DateJuly 9, 2024
Aasaan Loans IPO Listing DateJuly 11, 2024
Face Value₹10 per share
Price₹65 to ₹68 per share
Lot Size2000 Shares
Issue Size6,570,000 shares of ₹10
(aggregating up to ₹44.68 Cr)
Fresh Issue6,258,000 shares of ₹10
(aggregating up to ₹42.55 Cr)
Offer for Sale312,000 shares of ₹10
(aggregating up to ₹2.12 Cr)
Issue TypeBook Built Issue IPO
Listing AtNSE SME

Ambey Laboratories IPO GMP Today:

DateGMPListing GainKostakSubject to
Today₹2739.71%
3 July 2024₹2739.71%

Ambey Laboratories Limited IPO Details:

Ambey Laboratories, established in 1985, specializes in producing agrochemical products designed for crop protection. With nearly 40 years of experience, the company has been a reliable partner in the agrochemical industry.

Core Products:

  • 2,4-D Acid 98% TC
  • 2,4-D Sodium 95% SP
  • 2,4-D Amine (866 | 720 | 480g/l SL)
  • 2,4-D Ethyl Hexyl Ester 96% TC
  • 2,4-D Ethyl Ester 96% TC
  • Chlorpyriphos (97% TC / 20% EC / 50% EC)
  • Thiamethoxam (96% TC / 25% WG / 75% SG)
  • Pretilachlor (95% TC / 50% EC / 37% EW)
  • Metribuzin (97% TC / 70% WS)
  • Hexaconazole (92% TC / 5% SC / 5% EC / 10% EC)
  • Metalaxyl (98% TC / 35% WS)

Trusted by Industry Leaders: Ambey Laboratories serves prominent clients such as Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd.

Certified Excellence: Their state-of-the-art manufacturing facility in Behror, Rajasthan, holds certifications for ISO 9001:2015 from the Quality Research Organization and ISO 14001:2015 from the United Accreditation Foundation, ensuring top-notch quality and environmental standards.

Dedicated Workforce: As of October 31, 2023, Ambey Laboratories employs 220 skilled professionals across various departments, committed to delivering high-quality agrochemical solutions.

Ambey Laboratories IPO More Details Click Here

Ambey Laboratories IPO FAQs

When is Ambey Laboratories IPO open?

Ambey Laboratories IPO will open on 4 July 2024.

When is Ambey Laboratories IPO Close?

Ambey Laboratories IPO will be closed on 8 July 2024.

What is Ambey Laboratories IPO GMP Today?

The Ambey Laboratories IPO GMP aka Grey Market Premium is ₹27.

What is Ambey Laboratories IPO Kostak Rates Today?

The Ambey Laboratories IPO Kostak Rate is ₹000.

What is Ambey Laboratories IPO Subject to Sauda Price Today?

The Ambey Laboratories IPO subject to sauda rates is ₹000.

Ambey Laboratories IPO Expected Returns?

The Ambey Laboratories expected return is 39.71%.

How much will be the listing gain in Ambey Laboratories IPO?

Ambey Laboratories IPO will get listing gain of 39.71%. (Approx.)

Leave a Reply

Your email address will not be published. Required fields are marked *